ES8702393A1 - Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina - Google Patents

Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina

Info

Publication number
ES8702393A1
ES8702393A1 ES541728A ES541728A ES8702393A1 ES 8702393 A1 ES8702393 A1 ES 8702393A1 ES 541728 A ES541728 A ES 541728A ES 541728 A ES541728 A ES 541728A ES 8702393 A1 ES8702393 A1 ES 8702393A1
Authority
ES
Spain
Prior art keywords
derivative
benzyl
compounds
processes
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541728A
Other languages
English (en)
Spanish (es)
Other versions
ES541728A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of ES8702393A1 publication Critical patent/ES8702393A1/es
Publication of ES541728A0 publication Critical patent/ES541728A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES541728A 1984-03-30 1985-03-29 Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina Expired ES8702393A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59064464A JPS60222472A (ja) 1984-03-30 1984-03-30 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物

Publications (2)

Publication Number Publication Date
ES8702393A1 true ES8702393A1 (es) 1987-01-01
ES541728A0 ES541728A0 (es) 1987-01-01

Family

ID=13258978

Family Applications (3)

Application Number Title Priority Date Filing Date
ES541728A Expired ES8702393A1 (es) 1984-03-30 1985-03-29 Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina
ES556981A Expired ES8801237A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina
ES556980A Expired ES8801236A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES556981A Expired ES8801237A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina
ES556980A Expired ES8801236A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina

Country Status (10)

Country Link
US (1) US4663325A (enExample)
EP (1) EP0159566B1 (enExample)
JP (1) JPS60222472A (enExample)
AT (1) ATE31411T1 (enExample)
CA (1) CA1248110A (enExample)
DE (1) DE3561199D1 (enExample)
ES (3) ES8702393A1 (enExample)
FI (1) FI79101C (enExample)
GR (1) GR850787B (enExample)
NO (1) NO163185C (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
JPS62277370A (ja) * 1986-02-04 1987-12-02 Terumo Corp ジエン誘導体およびこれを含有する血管拡張剤
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung
AU646926B2 (en) * 1991-03-20 1994-03-10 Duphar International Research B.V. Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity
FI953748A7 (fi) * 1993-12-08 1995-08-07 Alcon Lab Inc Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksi danttiaktiivisuus sekä niiden käyttö solua suojaavina aineina
PT1051973E (pt) * 1998-01-29 2004-11-30 Akzo Nobel Nv Agentes de melhoramento da circulacao optica papilar
RU2204556C2 (ru) * 2001-06-18 2003-05-20 Федеральное государственное унитарное предприятие "Новокузнецкий научно-исследовательский химико-фармацевтический институт" Способ получения 1-(парахлорбензгидрил)-4-(2-оксиэтил)пиперазина
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
US7403561B2 (en) 2003-04-04 2008-07-22 Avid Technology, Inc. Fixed bit rate, intraframe compression and decompression of video
US7433519B2 (en) 2003-04-04 2008-10-07 Avid Technology, Inc. Bitstream format for compressed image data
WO2004093816A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
WO2004093813A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
AP2501A (en) * 2003-05-30 2012-10-22 Ranbaxy Lab Ltd Substituted pyrrole derivatives
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
AU2006223212A1 (en) * 2005-03-11 2006-09-21 Hong Kong Nitric Oxide Limited Combination therapy for endothelial dysfunction, angina and diabetes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
ATE551059T1 (de) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3r,5r)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
AR063469A1 (es) * 2006-07-14 2009-01-28 Ranbaxy Lab Ltd Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
AU2008220104B2 (en) 2007-02-28 2012-09-27 Asahi Kasei Pharma Corporation Sulfonamide derivative
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN102936233B (zh) * 2012-11-16 2016-01-20 葛长乐 一种1-(二(4-氟苯基)甲基)-4-(2,3,4-三甲氧苯基)哌嗪二盐酸盐晶型
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN107636792B (zh) * 2015-10-20 2019-05-14 韩国标准科学研究院 易于位置调节的电子显微镜用电子枪及包括其的电子显微镜
CN109666008A (zh) * 2018-12-31 2019-04-23 辰欣药业股份有限公司 一种盐酸洛美利嗪的合成方法
CN119119023A (zh) 2019-01-18 2024-12-13 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705979A (en) * 1951-03-22 1954-03-24 Henri Morren 1.4-aralkyl piperazines and process for the preparation thereof
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR1303080A (fr) * 1961-07-25 1962-09-07 Science Union Et Compagnie Soc Pipérazines disubstituées
NL7306771A (enExample) * 1972-06-02 1973-12-04
DE2900810A1 (de) * 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent

Also Published As

Publication number Publication date
CA1248110A (en) 1989-01-03
FI79101B (fi) 1989-07-31
GR850787B (enExample) 1985-11-25
FI851217L (fi) 1985-10-01
EP0159566A1 (en) 1985-10-30
NO163185C (no) 1990-04-18
JPS60222472A (ja) 1985-11-07
FI851217A0 (fi) 1985-03-26
FI79101C (fi) 1989-11-10
JPH0313232B2 (enExample) 1991-02-22
DE3561199D1 (en) 1988-01-28
ES556981A0 (es) 1988-01-01
EP0159566B1 (en) 1987-12-16
ES556980A0 (es) 1988-01-01
ES8801236A1 (es) 1988-01-01
ES8801237A1 (es) 1988-01-01
ES541728A0 (es) 1987-01-01
NO851298L (no) 1985-10-01
US4663325A (en) 1987-05-05
ATE31411T1 (de) 1988-01-15

Similar Documents

Publication Publication Date Title
ES8801237A1 (es) Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina
AU538424B2 (en) Piperazino phenylindane
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
ES377906A1 (es) Procedimiento de preparacion de nuevos derivados tricicli- cos.
IE820401L (en) N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines
ATE21246T1 (de) Substituierte imidazol-derivate mit pharmakologischer wirkung sowie ihre herstellung und verwendung.
JPS562968A (en) Novel pyrimidine derivative
ES2172376A1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK156064C (da) Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
ES452735A1 (es) Un procedimiento para preparar compuestos de aroilfenilnaf- taleno.
ES481855A1 (es) Procedimiento para la preparacion de nuevos revidados de 6- metoxi-2-acetilnaftaleno oxima con actividad analgesica.
GB1433472A (en) Biphenylyl ethers and their preparation
IE36485B1 (en) Benzothiophene derivatives and process for preparing same
GB1340637A (en) Dibenzocycloheptadioxolan derivatives
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
PT72255B (de) Neue substituierte 4-amino-2,6-diaryl-tetrahydrothiopyrane deren saureadditionssalze verfahren zu ihrer herstellung ihre verwendung und pharmazeutische zusammensetzungen
JPS5318581A (en) Novel o-nitrobutyrophenone derivatives
ES447349A1 (es) Un procedimiento para la preparacion de nuevos derivados delacido 8-azaprostanoico.
JPS57116052A (en) Quinazoline derivative and its preparation
KR930021617A (ko) 신규의 아릴피페리딘 유도체, 그의 제조방법 및 이를 함유하는 제약 조성물
DK214884A (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061014